BackAdvanced Health Intelligence Overview

Advanced Health Intelligence EBIT

Latest ebit for AHI: $-18M, below the Technology sector average of $80T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$4.78M
↓ 75.96% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$17.95M
↓ 55.45% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Advanced Health Intelligence (AHI) FAQ

The latest EBIT for AHI is $-18M as of June 2024. That compares with $-12M in the prior-year period — down 55.5% year over year. That is below the Technology sector average of $80T. Investors often review this figure alongside Advanced Health Intelligence's historical trend and sector peers before judging valuation or financial health.

Over the past year, AHI's EBIT moved from $-12M to $-18M — a 55.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Advanced Health Intelligence's operating scale or balance-sheet position.

Against Technology companies, AHI currently prints $-18M for EBIT, while the sector average sits near $80T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Advanced Health Intelligence's growth, margins, and balance sheet.

A EBIT figure of $-18M for AHI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $80T. Explore the charts below for those layers of context.

After noting AHI's EBIT ($-18M), review year-over-year change from $-12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.